WILL MY BABY GET TAKEN AWAY IF I HAVE TAKEN TRAMADOL UNPERSCRIBED WHEN I GIVE BIRTH??

Question

WILL MY BABY GET TAKEN AWAY IF I HAVE TAKEN TRAMADOL UNPERSCRIBED WHEN I GIVE BIRTH??

Answer 1

if it is harmful for your baby, thn your baby might get hurt, dont take it

Answer 2

Can only hope! Poor baby!

Answer 3

Has anyone asked you about using Tramadol? Why do you think they might take your baby?  

Answer 4

are you taking it for fun? probably not if you are taking it occasionally for pain, but i would say something to your dr just in case there are major side effects or if it causes birth defects...

Answer 5

Why the h**l would you do that?  That is a fairly strong painkiller, and could do damage to both of you.  If this is something that you plan on doing then you might deserve it.

Answer 6

They could take you away...heh...

No, but you need to kick your addiction to prescription pain killers. Be sure to get some counseling and perhaps a druge rehabilitation program so that you are no longer needing to take it.  

Answer 7

If you are so freaked out about the pain of birth just make sure you get the epidural you will be fine.  DO NOT RISK taking any type of drug that is not prescribed to you when you are pregnant. .  

Answer 8

Not if you live in Florida.  My daughter took cocaine during her whole pregnancy, was high when she went in to give birth.  Baby was born addicted and spent the first 6 days of her life going through de-tox.  And nobody even cared, except me.  

Answer 9

Tramadol may cause serious, even fatal side effects to an unborn child.  Stop taking it!

Answer 10

Ok I'm not sure why you would want to take a Narcotic analgesics after your give birth. Have you had a drug problem in the past, (I'm really not trying to be rude, but help you).

Tramadol is a SCHEDULE 4 medication. (ALL drugs fall under a category, 1 to 8)

Schedule 4 drugs are CONTROLLED DRUGS SUBJECT TO THE REQUIREMENTS OF REG ULATIONS.

This includes a perscription to get this medication and this is done because its classed as a danerous drug.

some adverse reactions

Cardiovascular. Uncommon: orthostatic dysregulation (tendency to collapse and cardiovascular collapse) and tachycardia, flushing. Rare: increase in blood pressure, bradycardia.

Respiratory. Rare: dyspnoea. Very rare: worsening of asthma (causality not established), respiratory depression (when the recommended doses are considerably exceeded and other respiratory depressant substances are administered concomitantly).

Gastrointestinal. Very common: nausea. Common: vomiting, constipation. Uncommon: dyspepsia, diarrhoea, abdominal pain, flatulence, urge to vomit. Rare: changes in appetite. Very rare: elevated liver enzymes.

Neurological. Very common: dizziness. Common: autonomic nervous effects (mainly dry mouth, perspiration), headache, sedation, asthenia, fatigue. Uncommon: trembling. Rare: changes in mood (usually elevation, occasionally dysphoria), paraesthesia, hallucinations, confusion, coordination disturbance, sleep disturbance, anxiety, nightmares, motor system weakness, changes in appetite, tremor, respiratory depression, seizures, involuntary muscle contractions, changes in activity (usually suppression, occasionally increase), changes in cognitive and sensorial capacity (e.g. decision behaviour, perception disorders), syncope.

Endocrine. Very rare: syndrome of inappropriate antidiuretic hormone secretion characterised by hyponatraemia secondary to decreased free water excretion.

Hypersensitivity and skin. Common: sweating. Uncommon: skin reactions, pruritus, rash. Rare: shock reactions, anaphylaxis, allergic reactions.

Genitourinary. Rare: micturition disorders (difficulty in passing urine and urinary retention), dysuria.

Special senses. Rare: visual disturbance (blurred vision).

The incidence of CNS irritation (dizziness), autonomic nervous effects (perspiration), orthostatic dysregulation (tendency to collapse and cardiovascular collapse) and tachycardia, and nausea/ urge to vomit/ vomiting can be increased with rapid intravenous administration and also tends to be dose dependent. No tests of significance have been performed.

Drug abuse and dependence. Although tramadol can produce drug dependence of the mu-opioid type (like codeine or dextropropoxyphene) and potentially may be abused, there has been little evidence of abuse in clinical experience to date. In clinical trials, tramadol produced some effects similar to an opioid, and at supratherapeutic doses was recognised as an opioid in subjective/ behavioural studies. Part of the activity of tramadol is thought to be derived from its active metabolite, which is responsible for some delay in onset of activity and some extension of the duration of mu-opioid activity. Delayed mu-opioid activity is believed to reduce a drug's abuse liability.

Tolerance and withdrawal. Tolerance development has been reported to be relatively mild. Symptoms of withdrawal reactions, similar to those occurring during opiate withdrawal, may occur as follows: agitation, anxiety, nervousness, insomnia, hyperkinesia, tremor and gastrointestinal symptoms. Other symptoms that have very rarely been seen with tramadol discontinuation include panic attacks, severe anxiety, hallucinations, paraesthesiae, tinnitus and unusual CNS symptoms.

Use in pregnancy. (Category C)

There are no adequate and well controlled studies with tramadol in pregnant women, therefore tramadol should not be used during pregnancy. Studies in animals using intravenous or intramuscular routes of administration have not been conducted.

Tramadol has been shown to be embryotoxic and fetotoxic in mice, rats and rabbits at maternally toxic doses of 120 mg/kg in mice, or higher in rats and 75 mg/kg in rabbits, but was not teratogenic at these dose levels. No harm to the fetus due to tramadol was seen at doses that were not maternally toxic.

No drug related teratogenic effects were observed in progeny of mice, rats or rabbits treated with tramadol (75 mg/kg for rats or 175 mg/kg for rabbits). Embryo and fetal toxicity consisted primarily of decreased fetal weights, skeletal ossification and increased supernumerary ribs at maternally toxic dose levels. Transient delays in development or behavioural parameters were also seen in pups from rat dams allowed to deliver. Embryo and fetal lethality were reported only in one rabbit study at 300 mg/kg, a dose that would cause extreme maternal toxicity in the rabbit.

In perinatal and postnatal studies in rats, progeny of dams receiving oral (gavage) do

Answer 11

YES YOUR BABY WILL DIE

Answer 12

No, they don'tt check you for anything like that, usually only illegal drugs